The effectiveness of N-acetylcystein (NAC) on accelerating renal failer recovery
Phase 3
- Conditions
- eptospirosis - Acute renal failer.Leptospirosis
- Registration Number
- IRCT20190727044343N4
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
People with Glomerular Filteration Rate (GFR) have less than 60 studies.
People whose leptospirosis has been confirmed by Enzym-Linked Immunosorbent Assay (ELISA) or Microscopic Agglutination Test (MAT) .
Satisfaction to participate in the study.
Exclusion Criteria
Diabetics are excluded from the study.
People with underlying liver disease are excluded from the study.
People with underlying kidney disease excluded from the study.
Patients who have been hospitalized with sepsis symptoms prior to refferal.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decreased mean serum creatinine levels. Timepoint: Measurement of serum creatinine levels on days 0,3 and 7 after initiation of treatment. Method of measurement: Blood serum sample.
- Secondary Outcome Measures
Name Time Method Improved glomerular filtration rate. Timepoint: 0,3and days to start treatment. Method of measurement: Blood serum sample.